Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 15, 2024
Fusion Antibodies PLC
Depreciation & Amortization
|
Fusion Antibodies PLC
Depreciation & Amortization Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Depreciation & Amortization
£249k
|
CAGR 3-Years
-28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Depreciation & Amortization
£41.6m
|
CAGR 3-Years
34%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Depreciation & Amortization
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Depreciation & Amortization
£3m
|
CAGR 3-Years
119%
|
CAGR 5-Years
157%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Depreciation & Amortization
£5.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Depreciation & Amortization
£2.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
27%
|
CAGR 10-Years
57%
|
See Also
What is Fusion Antibodies PLC's Depreciation & Amortization?
Depreciation & Amortization
249k
GBP
249k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Depreciation & Amortization amounts to 249k GBP.
What is Fusion Antibodies PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
3%
3%
Over the last year, the Depreciation & Amortization growth was -60%. The average annual Depreciation & Amortization growth rates for Fusion Antibodies PLC have been -28% over the past three years , 3% over the past five years .
You don't have any saved screeners yet
